Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 7 studies | 24% ± 6% | |
enterocyte | 6 studies | 26% ± 4% | |
epithelial cell | 4 studies | 30% ± 13% |
Insufficient scRNA-seq data for expression of UGT2A3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 2811.06 | 89 / 89 | 81% | 152.51 | 730 / 901 |
liver | 97% | 1067.50 | 220 / 226 | 54% | 24.90 | 221 / 406 |
pancreas | 100% | 1454.52 | 327 / 328 | 51% | 26.81 | 91 / 178 |
intestine | 50% | 2377.58 | 479 / 966 | 24% | 10.64 | 125 / 527 |
stomach | 7% | 20.79 | 25 / 359 | 26% | 18.25 | 73 / 286 |
bladder | 0% | 0 | 0 / 21 | 10% | 6.02 | 51 / 504 |
esophagus | 0% | 0.54 | 3 / 1445 | 8% | 6.95 | 14 / 183 |
lung | 0% | 0 | 0 / 578 | 4% | 2.11 | 45 / 1155 |
uterus | 0% | 0 | 0 / 170 | 1% | 0.94 | 5 / 459 |
breast | 0% | 3.07 | 2 / 459 | 0% | 0 | 0 / 1118 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 1.73 | 1 / 230 |
spleen | 0% | 2.18 | 1 / 241 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.06 | 1 / 430 |
peripheral blood | 0% | 1.26 | 2 / 929 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.32 | 2 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 0% | 0 | 0 / 705 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
skin | 0% | 0 | 0 / 1809 | 0% | 0 | 0 / 472 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0052695 | Biological process | cellular glucuronidation |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0016020 | Cellular component | membrane |
GO_0015020 | Molecular function | glucuronosyltransferase activity |
Gene name | UGT2A3 |
Protein name | UDP-glucuronosyltransferase 2A3 UDP-glucuronosyltransferase 2A3 (UDPGT 2A3) (EC 2.4.1.17) UDP glucuronosyltransferase family 2 member A3 |
Synonyms | UNQ2559/PRO6239 |
Description | FUNCTION: UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds (By similarity). . |
Accessions | ENST00000611042.3 ENST00000626124.1 D6RBL8 Q6UWM9 ENST00000503012.1 ENST00000251566.9 A0A0G2JRR8 |